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EVIDENCE THAT CANINE PANCREATIC ISLETS PROMOTE THE SURVIVAL OF HUMAN HEPATOCYTES 
IN NUDE MICEl 
In the last 15 years there have been numerous reports dem-
onstrating that transplanted hepatocytes can retain hepatocel-
lular functions (1), correct congenital enzyme deficiencies (2-
4), and improve survival rates in animal models of acute hepatic 
failure (5-7). Recently, Moscioni et a1. (8) showed that human 
liver cells attached to collagen-coated microcarriers (9, 10) 
were able to correct metabolic defects following transplantation 
into mutant rat recipients that were genetically deficient in 
either bilirubin-uridine diphosphate glucuronosyltransferase 
activity or albumin synthesis. Interestingly, the intraperito-
neally injected hepatocyte-microcarriers that were well vascu-
larized were almost exclusively found on the surface of the 
pancreas. This apparent cellular tropism raises questions about 
the presence and mechanism of action of pancreas-derived 
hepatotrophic factors and their role in the maintenance of 
hepatocyte integrity (11-14). 
The aim of this study was to determine the effect of pan-
creatic islets on the survival of human hepatocytes in an ectopic 
site in nude mice. Human hepatocytes were obtained from 
segments of preserved cadaver donor livers that had been 
discarded during size reduction procedures before transplanta-
tion of the residual fragments to pediatric recipients. A modi-
fication of the automated procedure for isolation of human 
pancreatic islets (15) was used for the isolation of hepatocyte 
aggregates. After cannulation of its portal branch, the liver 
segment was perfused with 200 ml of a solution of 1 mg/ml 
collagenase (Boehringer-Mannheim, type P) in Hanks solution 
(28°C) and placed into a digestion chamber. Separation of 
hepatocellular clusters was accomplished by the same separa-
tion procedure used previously for isolation of human pan-
creatic islets (15). Between 80% and 95% of the harvested 
hepatocytes were viable, as assessed by trypan blue exclusion. 
Collagen-coated microcarriers (Cytodex 3, Pharmacia Fine 
Chemicals, Upsala, Sweden) were prepared as described by 
Demetriou et al. (9). Pancreatic islets were obtained from the 
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pancreata of mongrel dogs (18-25 kg) by a modification (16) 
of the automated method for human islet isolation (15). 
Male BALB/c nude mice (20 g) were used as recipients in 
three groups (n=6 in each group). In group 1 (control) approx-
imately 4000 hepatocyte clusters of an average diameter of 150 
p. were placed beneath the left renal capsule as previously 
described (17). In group 2 (secondary control), hepatocyte 
clusters were transplanted in combination with 400 collagen-
coated microcarriers. In group 3 the same number of hepatocyte 
clusters was transplanted without microcarriers but in combi-
nation with 400 pancreatic islets of 150 p.m average diameter. 
Thirty days after transplantation the nude mice were sacri-
ficed and the morphologic integrity of the renal subcapsular 
grafts was determined histopathologically. Hematoxylin-eosin 
stain was used in all sections. In addition, immunostain for 
insulin (immunoperoxidase) was used in sections of combined 
islet-hepatocyte transplants to distinguish the islets from the 
hepatocellular implants. 
The pathologist, who was blinded to the experimental groups 
from which the specimens came, correctly and without excep-
tion matched the tissues to the groups as follows. No hepato-
cytes were detectable in the renal subcapsular implants 1 month 
after transplantation of hepatocyte clusters alone (group 1). In 
group 2, the addition of collagen -coated microcarriers to the 
hepatocellular aggregates resulted in the survival of a thin rim 
of epithelioid cells attached to the microcarriers, while the 
remaining hepatocytes degenerated, leaving only fibrosis and a 
nonspecific mononuclear cell infiltrate around the microcar-
riers in the transplant site (Fig. 1). This suggested a minor 
augmentation of hepatocellular survival by the microcarrier. In 
contrast, when islets were included at the transplant site (group 
3) multilayers of human hepatocytes were found. The surviving 
hepatocytes were healthy, in large clumps, and glycogen-con-
taining, PAS-positive, and diastase-sensitive. These results are 
consistent with previous demonstrations that pancreatic-de-
rived hepatotrophic factors are essential for maintenance of 
hepatocyte integrity (11-14). Scattered pancreatic islets were 
detected (Fig. 2). 
In past experience, when hepatocytes were transplanted by 
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FIGURE 1. Photomicrograph of combined human hepatocytes and 
collagen-coated microcarriers 4 weeks after renal subcapsular trans-
plantation. Degeneration of the hepatocytes occurred, leaving only a 
thin rim of epithelioid cells attached to the microcarriers (M) (H&E 
stain; original magnification XI 20) . 
FIGURE 2. Photomicrograph of combined human hepatocytes and 
dog pancreatic islets 4 weeks after renal subcapsular transplantation 
in nude mice. Insulin immunoperoxidase (dark) stain distinguished 
islets (I) from the human hepatocytes (H), which appeared well pre-
served in the combined transplants (original magnification xI80). 
themselves in the presence of an intact host liver, no evidence 
of hepatocyte proliferation could be observed at any time after 
transplantation (18). Whenever cells without nuclei and multi-
nucleated cells were found at the transplant site (I9) , hepatic 
degeneration had occurrecL Similarly, it was not possible to 
detect the hepatocytes at either 2 or 4 days after intrasplenic 
transplantation (20), except when there was a proliferative 
stimulus provided by 70% recipient hepatectomy. Using the 
model of Demetriou et al. (9, 10), the collagen-coated hepato-
cyte microcarriers, the microcarriers may have promoted the 
survival of a small number of hepatocytes. In the earlier exper-
iments of Moscioni et al. (8), the selective survival of the 
intraperitoneally injected hepatocyte-microcarrier aggregates 
on the surface of the pancreas was congruent with the possible 
role of factors produced from the pancreas in the maintenance 
of normal hepatocytes . Direct evidence supporting this concept 
(11-14) has come from rodent experiments in which combined 
hepatocyte-islet clusters were placed in ectopic sites (21, 22). 
The present study has established that human hepatocytes 
are subject to the hepatotrophic influence of islet cell factors, 
and because dog islets were used with human hepatocytes in 
the nude mouse recipient, it could be shown that the hepato-
trophic effect was not species-specific. These findings will be 
important in defining effective procedures for the maintenance 
of human hepatocytes both in vitro and in vivo, and for their 
use in hepatocellular transplantation, artificial liver, and gene 
therapy applications. 
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